Notably, CCL2 was uniquely enriched in glycosphingolipid biosynthesis and type I diabetes mellitus pathways, indicating its potential role in bridging metabolic and inflammatory processes. This evidence concerns the gene CCL2 and type 1 diabetes mellitus.